Principal Secretary (PS) Oluga Calls for Strategic Reforms in Kenya's Blood Transfusion and Transplant Services to Support Universal Health Coverage (UHC) Goals
During a meeting with the Kenya Blood Transfusion and Transplant Services (KBTTS) team, he stressed the importance of efficient planning, optimized supply chains, and equipment modernization to ensure safe and consistent blood availability across the country.
Dr. Oluga identified governance as a key challenge and urged the team to prioritize the public good over individual interests. He emphasized the importance of unity, accountability, and innovation to align their work with the national health agenda. He also stressed the need for strengthened policy frameworks for transplant services and the expansion of external partnerships and philanthropic support.
The PS reaffirmed the Ministry's commitment to addressing operational, human resource, and infrastructure challenges, urging the team to rethink the funding model and optimize the limited resources available to meet the sector's needs.
Significant progress has been made in the blood transfusion services, with the Directorate of Blood Transfusion and Transplant Services transitioning from whole blood to blood components in line with WHO guidance. The Directorate is also advancing blood management through the Damu-KE system, with six regional centres and full capacity across all 47 counties.
In the last financial year, the Directorate surpassed its target by collecting 449,000 units of blood and blood components. Dr. Patrick Amoth, Director General for Health, commended the team and called for an increased focus on resource mobilization, county-level partnerships, and the expediting of the Blood Transfusion Bill.
Distributed by APO Group on behalf of Ministry of Health, Kenya.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
10 hours ago
- Zawya
Egypt: B Healthcare Investments to raise capital to $20mln
Arab Finance: B Healthcare Investments, a subsidiary of B Investments Holding, is close to obtaining the necessary approvals to increase its capital to EGP 1 billion, according to a bourse filing. The transaction will be executed through the entry of new investors, such as the Commercial International Bank (CIB) and Al Baraka Bank Egypt, along with Misr Insurance and Misr Life Insurance. This is in addition to existing shareholders, such as the Sovereign Fund of Egypt's (TSFE) Healthcare and Pharma Sub-fund, and a businessman. This move aims to finance the company's expansion plans within Egypt and other Gulf countries. © 2025 All Rights Reserved Arab Finance For Information Technology Provided by SyndiGate Media Inc. (
Khaleej Times
14 hours ago
- Khaleej Times
Meeting every child where they are: ABLE UK offers personalised, multidisciplinary paediatric therapy services in Dubai
ABLE UK is founded on one core belief: each child is unique, and their care plan should reflect that. The centre works with children of all ages facing developmental delays, including autism spectrum disorder, ADHD, learning difficulties, and other behavioural or neurological challenges. Whether a child is dealing with speech delays, coordination issues, sensory processing differences, or more complex diagnoses, the team delivers personalised, evidence-based interventions tailored to their strengths, needs, and environment. All services are offered in one convenient location at Building 33 – 1st and 2nd Floor, Dubai Healthcare City, ensuring integrated care and easier access for families. The centre's comprehensive range of therapies includes: Applied Behaviour Analysis (ABA): A research-backed approach for children with autism or behavioural needs, enhancing communication, learning, and social skills through structured reinforcement. Occupational Therapy (OT): Helping children build essential life and learning skills for independence. Myofunctional Therapy (MFT): Addressing breathing and oral function issues that affect facial growth and development. Speech and Language Therapy (SLT): Supporting expressive, receptive, and social communication in children facing language delays or articulation issues. Oral Placement Therapy (OPT) & Feeding Therapy (FT): Improving oral motor skills and feeding for children with sensory or motor-based challenges. Physiotherapy (PT): Supporting mobility, strength, and coordination for children with neurological or physical needs, including expertise in working with preterm infants. Psychological Assessments: Led by in-house clinical psychologist Mr. Joey Sura, the diagnostic services identify developmental, learning, or attention challenges. The team also supports schools by providing assessments for children who need accommodations. STEPS Transition Programme: Designed to prepare children for mainstream or special education settings, STEPS run according to the school calendar and builds both academic and functional school-readiness skills. This includes pre-literacy, numeracy, classroom behaviour, social interaction, and daily routines, offering a smooth and confident transition into formal education. Training & Mentorship: Intensive training programmes are provided for the in-house team, parents, and the broader professional community. ABLE UK also mentors newly graduated professionals and regularly invites global experts to the UAE for specialist workshops. In-house Training Centre Facility: This space is designed to host professional training programmes, workshops, and events. It supports ongoing development for the team, parents, and the wider community through expert-led sessions, mentorship, and hands-on learning opportunities. Expanding into DMCC To meet growing demand, ABLE UK has opened a new branch in Jumeirah Lakes Towers (DMCC), offering families in central and southern Dubai easier access to the full range of multidisciplinary services. The new branch maintains the same high standard of care, aligned with the mission to make expert intervention accessible and timely. Beyond therapy: Advocating for inclusion On July 25, 2025, ABLE UK was recognised by the Hidden Disabilities Sunflower program, becoming one of the first paediatric centres in the Middle East to receive this honour. This global initiative promotes understanding and visibility for people with non-visible disabilities in schools, airports, and other public spaces. Aman Sura, director of ABLE UK, shared: 'Joining the Sunflower initiative reflects our commitment to inclusion. We want every child-whether their challenges are visible or not to feel supported and seen.' Gursaran Sura, CEO and co-founder, added: 'When we started in 2015 with a small team, we knew the UAE needed a child-first, integrated therapy model. Today, we've helped hundreds of children build not just skills, but confidence. Many are now thriving in mainstream schools and daily life.' ABLE UK is also proud of its culturally responsive care. With many children in the UAE growing up bilingual or multilingual, therapists adapt assessments to reflect linguistic and cultural diversity, ensuring results are accurate and meaningful. Real-life results, lasting change What sets ABLE UK apart is its commitment to ongoing growth. The team actively refines tools and interventions based on real-life conditions - such as attention span, environment, and motivation so that gains made in the clinic transfer to the home, school, and beyond. Parents consistently describe their experience at ABLE UK as transformative. One mother shared: 'We had visited several clinics before, but only at ABLE UK did we feel truly understood. They didn't just assess our son - they built a plan that worked and supported us throughout.' Because services are integrated, families experience fewer delays and more consistent, collaborative support. Psychologists, therapists, and educators work in sync to ensure each child receives the right help at the right time. A message to families: Don't wait If there's one message ABLE UK hopes families take to heart, it's this: early action matters. Intervening during the early developmental years can make a profound difference in a child's path. Waiting often leads to increased emotional, social, and academic difficulties later on. As one of the lead psychologists puts it: 'A diagnosis isn't a label - it's a roadmap. It gives families clarity, direction, and most importantly, options.' With over 350 children supported weekly across more than 17,000 sq ft of world-class therapy space, ABLE UK is more than a clinic. It's a centre of possibility, inclusion, and lasting impact. To learn more, visit:
Zawya
3 days ago
- Zawya
Kenya certified for elimination of human African trypanosomiasis (sleeping sickness)
The World Health Organization (WHO) has validated Kenya as having eliminated human African trypanosomiasis (HAT) or sleeping sickness as a public health problem, making it the tenth country to reach this important milestone. HAT is the second neglected tropical disease (NTD) to be eliminated in Kenya: the country was certified free of Guinea worm disease in 2018. 'I congratulate the government and people of Kenya on this landmark achievement,' said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. 'Kenya joins the growing ranks of countries freeing their populations of human African trypanosomiasis. This is another step towards making Africa free of neglected tropical diseases'. HAT a vector-borne disease caused by the blood parasite Trypanosoma brucei. It is transmitted to humans through the bites of tsetse flies that have acquired the parasites from infected humans or animals. Rural populations dependent on agriculture, fishing, animal husbandry or hunting are most at risk of exposure. As the name indicates, HAT is transmitted only on the African continent. The disease exists in two forms, gambiense and rhodesiense. The rhodesiense form, which is found in eastern and southern Africa, is the only one present in Kenya. It is caused by Trypanosoma brucei rhodesiense (r-HAT) and progresses rapidly invading multiple organs including the brain. Without treatment, it is fatal within weeks. Kenya's progress 'This validation marks a major public health milestone for Kenya, as we celebrate the elimination of a deadly disease in our country. The achievement will not only protect our people but also pave the way for renewed economic growth and prosperity,' said Dr Aden Duale, Kenya's Cabinet Secretary for Health. 'This follows many years of dedication, hard work and collaboration'. The first cases of HAT in Kenya were detected in the early 20 century. Since then, Kenya has engaged in consistent control activities, without indigenous new cases reported for over 10 years. The last autochthonous case was detected in 2009, and the last two exported cases, infected in the Masai Mara National Reserve, were detected in 2012. Recently, Kenya strengthened HAT surveillance in 12 health facilities in six historically endemic counties to act as sentinel sites. They were equipped with diagnostic tools and had their clinical personnel trained on diagnostic procedures, including the most sensitive and practical tests for r-HAT. The country also actively monitors the control and surveillance of tsetse flies and animal trypanosomiasis, both within and beyond the historical HAT endemic areas, supported by the national veterinary health authorities and the Kenya Tsetse and Trypanosomiasis Eradication Council (KENTTEC). These activities and the related data provide supplementary backing to the claim of HAT elimination as a public health problem. 'This key milestone reflects Kenya's efforts and commitment over many years, as a collaboration between national and county governments, national research institutions, development partners and affected communities,' said Dr Patrick Amoth, EBS, Director General Health, Ministry of Health, Kenya. 'The country remains fully committed to sustain the quality of care and surveillance in line with WHO's recommendations'. Supported by WHO and partners, including FIND, Kenya's HAT elimination programme will now implement a post-validation surveillance plan to detect any potential resurgence or reintroduction of transmission. WHO continues to support ongoing monitoring in previously affected areas and maintains a stock of medicines to ensure rapid treatment of possible future cases, thanks to donations from Bayer AG and Sanofi. 'This success was made possible by the Ministry of Health's leadership, the dedication of health workers in areas at risk and the support from key partners,' said Dr Abdourahmane Diallo, WHO Representative to Kenya. 'WHO is proud to have contributed to this achievement and encourages all stakeholders to remain involved in post-validation monitoring'. Progress in global HAT elimination A total of 57 countries have eliminated at least one NTD. Of these, 10 (including Kenya) have successfully eliminated HAT as a public health problem. The other countries that have reached this milestone are Benin, Chad, Côte d'Ivoire, Equatorial Guinea, Ghana, Guinea, Rwanda, Togo and Uganda. Distributed by APO Group on behalf of World Health Organization - Kenya.
